Abstract
Almost all (99.9%) nucleotide bases are exactly the same in all people, however, the remaining 0.1% account for about 1.4 million locations where single-base DNA differences/polymorphisms (SNPs) occur in humans. Some of these SNPs, called non-synonymous SNPs (nsSNPs), result in a change of the amino acid sequences of the corresponding proteins affecting protein functions and interactions. This review summarizes the plausible mechanisms that nsSNPs may affect the normal cellular function. It outlines the approaches that have been developed in the past to predict the effects caused by nsSNPs with special emphasis on the methods that use structural information. The review provides systematic information on the available resources for predicting the effects of nsSNPs and includes a comprehensive list of existing SNP databases and their features. While nsSNPs resulting in amino acid substitution in the core of a protein may affect protein stability irreversibly, the effect of an nsSNP resulting to a mutation at the surface of a protein or at the interface of protein-protein complexes, could, in principle be, subject of drug therapy. The importance of understanding the effects caused by nsSNP mutations at the protein-protein and protein-DNA interfaces is outlined.
Keywords: nsSNP, residue mutation, disease-causing SNP, protein-protein interactions, protein stability
Current Pharmaceutical Biotechnology
Title: Approaches and Resources for Prediction of the Effects of Non-Synonymous Single Nucleotide Polymorphism on Protein Function and Interactions
Volume: 9 Issue: 2
Author(s): S. Teng, E. Michonova-Alexova and E. Alexov
Affiliation:
Keywords: nsSNP, residue mutation, disease-causing SNP, protein-protein interactions, protein stability
Abstract: Almost all (99.9%) nucleotide bases are exactly the same in all people, however, the remaining 0.1% account for about 1.4 million locations where single-base DNA differences/polymorphisms (SNPs) occur in humans. Some of these SNPs, called non-synonymous SNPs (nsSNPs), result in a change of the amino acid sequences of the corresponding proteins affecting protein functions and interactions. This review summarizes the plausible mechanisms that nsSNPs may affect the normal cellular function. It outlines the approaches that have been developed in the past to predict the effects caused by nsSNPs with special emphasis on the methods that use structural information. The review provides systematic information on the available resources for predicting the effects of nsSNPs and includes a comprehensive list of existing SNP databases and their features. While nsSNPs resulting in amino acid substitution in the core of a protein may affect protein stability irreversibly, the effect of an nsSNP resulting to a mutation at the surface of a protein or at the interface of protein-protein complexes, could, in principle be, subject of drug therapy. The importance of understanding the effects caused by nsSNP mutations at the protein-protein and protein-DNA interfaces is outlined.
Export Options
About this article
Cite this article as:
Teng S., Michonova-Alexova E. and Alexov E., Approaches and Resources for Prediction of the Effects of Non-Synonymous Single Nucleotide Polymorphism on Protein Function and Interactions, Current Pharmaceutical Biotechnology 2008; 9 (2) . https://dx.doi.org/10.2174/138920108783955164
DOI https://dx.doi.org/10.2174/138920108783955164 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor α(PPARα) Agonists,PPARγ Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells
Current Drug Targets - Cardiovascular & Hematological Disorders Mechanisms Involved in the Genesis of Diabetic Nephropathy
Current Diabetes Reviews The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial
Endocrine, Metabolic & Immune Disorders - Drug Targets Cigarette Smoking in Methadone Maintained Patients: An Up-to-Date Review
Current Drug Abuse Reviews Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Current Medicinal Chemistry The Role of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase Signaling in Cardiovascular Therapy
Current Signal Transduction Therapy Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Current Drug Targets Alzheimers and Dementia in the Oldest-Old: A Century of Challenges
Current Alzheimer Research Regulation of Vascular Genes by Glucose
Current Pharmaceutical Design Antimicrobial Agents-Associated with QT Interval Prolongation
Current Drug Safety Anaemia, Polycythaemia and Chronic Heart Failure
Current Cardiology Reviews Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects
Current Pharmaceutical Design The Genetic Background of Cholesterol Gallstone Formation: An Inventory of Human Lithogenic Genes
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Recent advances in the management of autoimmune myocarditis: insights from animal studies.
Current Pharmaceutical Design Difference in the Influence of the Lipid Profile as a Coronary Risk Factor in Patients with and Without Diabetes Mellitus
Vascular Disease Prevention (Discontinued) Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Current Cardiology Reviews Von Willebrand Factor and Thrombosis: Risk Factor, Actor and Pharmacological Target
Current Vascular Pharmacology Recents Patents for Isolating, Delivering and Tracking Adult Stem Cells in Regenerative Medicine
Recent Patents on Drug Delivery & Formulation Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases
Current Medicinal Chemistry Blood Platelet Reactivity and its Pharmacological Modulation in (People with) Diabetes Mellitus
Current Pharmaceutical Design